Clinical Trial Update: Desvenlafaxine vs. Placebo Treatment of Chronic Depression [Phase 4]

View source ↗

Summary

Phase 4 trial comparing desvenlafaxine to placebo in chronic depression shows completed study with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Dysthymia
• Dysthymic Disorder

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Dysthymic Disorder, Dysthymia | Phase 4 | Status: COMPLETED | Results posted: 2017-09-11